Scientists devise method for faster detection of rare leukemia

10/6/2008 | FDAnews · Yahoo!

U.S. researchers have developed a technique to detect juvenile myelomonocytic leukemia -- a rare type of the disease -- within a few hours rather than weeks. The method, which is based on flow cytometry, uses fluorescent-tagged antibodies to identify and organize cells that have the STAT5 protein in patients with the disease. The approach may prove useful in evaluating the efficacy of potential drug therapies against JMML and other conditions, researchers said.

View Full Article in:

FDAnews · Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD